SENP2 and heart failure: Since enhanced deSUMOylation in murine hearts through overexpression of SENP2 led to congenital heart defects and cardiac dysfunction (Kim et al., 2012), we require inhibitor(s) which efficiently bind to SENP2, inhibit SENP2, and are used for heart failure treatment.